These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24210190)

  • 1. Octreotide for chylous effusions in congenital diaphragmatic hernia.
    Landis MW; Butler D; Lim FY; Keswani S; Frischer J; Haberman B; Kingma PS
    J Pediatr Surg; 2013 Nov; 48(11):2226-9. PubMed ID: 24210190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide for treatment of chylothorax after repair of congenital diaphragmatic hernia.
    Goyal A; Smith NP; Jesudason EC; Kerr S; Losty PD
    J Pediatr Surg; 2003 Aug; 38(8):E19-20. PubMed ID: 12891519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Propranolol in the Treatment of Chylous Effusions in Infants.
    Mitchell K; Weiner A; Ramsay P; Sahni M
    Pediatrics; 2021 Jul; 148(1):. PubMed ID: 34187907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chylothorax in congenital diaphragmatic hernia.
    Zavala A; Campos JM; Riutort C; Skorin I; Godoy L; Faunes M; Kattan J
    Pediatr Surg Int; 2010 Sep; 26(9):919-22. PubMed ID: 20680634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chylothorax after repair of congenital diaphragmatic hernia--a case report.
    Cheah FC; Noraida MH; Boo NY; Amin TY
    Singapore Med J; 2000 Nov; 41(11):548-9. PubMed ID: 11284614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chylothorax after repair of congenital diaphragmatic hernia--risk factors and morbidity.
    Kavvadia V; Greenough A; Davenport M; Karani J; Nicolaides KH
    J Pediatr Surg; 1998 Mar; 33(3):500-2. PubMed ID: 9537566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chylothorax].
    Migliori C; Boroni G; Milianti S; Ekema G
    Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):89-91. PubMed ID: 21090078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diaphragmatic fenestration for refractory chylothorax after congenital cardiac surgery in infants.
    Kumar TKS; Balduf K; Boston U; Knott-Craig C
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2062-2068. PubMed ID: 28916211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of neonatal chylothorax with octreotide.
    Khatami SF; Parvaresh P
    Indian J Pediatr; 2011 Nov; 78(11):1412-4. PubMed ID: 21625833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus efficacy in the treatment of critically ill infants with congenital primary chylous effusions.
    Agarwal S; Anderson BK; Mahajan P; Fernandes CJ; Margolin JF; Iacobas I
    Pediatr Blood Cancer; 2022 Feb; 69(2):e29510. PubMed ID: 34889518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tube Thoracostomy at the Time of Congenital Diaphragmatic Hernia Repair: Reassessing the Risks and Benefits.
    Schlager A; Arps K; Siddharthan R; Clifton MS
    J Laparoendosc Adv Surg Tech A; 2017 Mar; 27(3):311-317. PubMed ID: 28051921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of somatostatin/octreotide treatment in neonates with congenital chylothorax.
    Yin R; Zhang R; Wang J; Yuan L; Hu L; Jiang S; Chen C; Cao Y
    Medicine (Baltimore); 2017 Jul; 96(29):e7594. PubMed ID: 28723800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide for management of chylothorax following bidirectional Glenn in a three-month-old infant.
    Wright SB; Mainwaring RD
    J Card Surg; 2009; 24(2):216-8. PubMed ID: 19267835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chylothorax after congenital diaphragmatic hernia repair.
    Gonzalez R; Bryner BS; Teitelbaum DH; Hirschl RB; Drongowski RA; Mychaliska GB
    J Pediatr Surg; 2009 Jun; 44(6):1181-5; discussion 1185. PubMed ID: 19524736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An idiopathic congenital chylothorax: surgery or conservative management?
    Perisson C; Nathan N; Larroquet M; Corvol H
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24788632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with OK-432 for persistent congenital chylothorax in newborn infants resistant to octreotide.
    Matsukuma E; Aoki Y; Sakai M; Kawamoto N; Watanabe H; Iwagaki S; Takahashi Y; Kawabata I; Kondo N; Uchida Y
    J Pediatr Surg; 2009 Mar; 44(3):e37-9. PubMed ID: 19302843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based management of chylothorax in infants.
    Church JT; Antunez AG; Dean A; Matusko N; Deatrick KB; Attar MA; Gadepalli SK
    J Pediatr Surg; 2017 Jun; 52(6):907-912. PubMed ID: 28342580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful use of somatostatin in a case of neonatal chylothorax.
    Au M; Weber TR; Fleming RE
    J Pediatr Surg; 2003 Jul; 38(7):1106-7. PubMed ID: 12861552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic congenital chylothorax treated with octreotide.
    Sousa PR; Leitão H; Camacho MC; Nunes JL
    BMJ Case Rep; 2010 May; 2010():. PubMed ID: 22750919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmatic [corrected] factor XIII reduces severe pleural effusion in children after open-heart surgery.
    Schroth M; Meißner U; Cesnjevar R; Weyand M; Singer H; Rascher W; Klinge J
    Pediatr Cardiol; 2006; 27(1):56-60. PubMed ID: 16082570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.